Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

The golden years: a tribute to Erminio Costa.

Authors:
Norton H Neff Maria Hadjiconstantinou

Pharmacol Res 2011 Oct 16;64(4):350-8. Epub 2011 Jun 16.

Department of Pharmacology, Division of Molecular Neuropsychopharmacology, The Ohio State University College of Medicine, 5067 Graves Hall, 333 W. 10th Avenue, Columbus, OH 43210, United States.

In June of 1968 the NIMH established the Laboratory of Preclinical Pharmacology (LPP) under the leadership of Erminio Costa at St. Elizabeths Hospital in Washington, DC. From its inception until 1985 more than 170 scientists produced over 800 scientific publications that largely influenced the direction of neuroscience research. Under Dr. Costa's scientific guidance LPP made numerous discoveries that contributed to the understanding of neuronal function and push the fledging field of neuroscience forward. Methods were developed to measure the turnover rate of catecholamines, serotonin, acetylcholine and GABA, and to assess the dynamic state of neuronal stores of peptides; the regulation of tyrosine hydroxylase activity was revealed; the molecular mechanisms underlying neurotransmitter receptor signaling and regulation were explored; the concept that opioid peptides function as neuromodulators in structures that are not involved in pain threshold regulation was proposed; the role of GABAergic transmission for the action of benzodiazepines was pioneered; the endogenous mechanisms operative in opiate tolerance were elucidated; and approaches to measure mRNA and evaluate its regulation were introduced. As a tribute to Dr. Costa, this article presents the initial journey and the many contributions to teaching and research that he made from 1963 to 1985, a period that I worked with him and call it "the golden years".

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.phrs.2011.05.013DOI Listing
October 2011

Publication Analysis

Top Keywords

erminio costa
8
elucidated approaches
4
acetylcholine gaba
4
serotonin acetylcholine
4
approaches measure
4
measure mrna
4
rate catecholamines
4
catecholamines serotonin
4
gaba assess
4
tolerance elucidated
4
stores peptides
4
regulation
4
neuronal stores
4
state neuronal
4
assess dynamic
4
dynamic state
4
turnover rate
4
mrna evaluate
4
push fledging
4
proposed role
4

Similar Publications

Acute imidazenil treatment after the onset of DFP-induced seizure is more effective and longer lasting than midazolam at preventing seizure activity and brain neuropathology.

Authors:
Bashkim Kadriu Alessandro Guidotti Erminio Costa John M Davis James Auta

Toxicol Sci 2011 Mar 22;120(1):136-45. Epub 2010 Nov 22.

Department of Psychiatry, The Psychiatric Institute, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612, USA.

Diazepam (DZ), the preferred anticonvulsant benzodiazepine (BZ) for the treatment of organophosphate (OP) nerve agent-induced seizures and neuronal damage, has been associated with unwanted effects such as sedation, amnesia, cardiorespiratory depression, anticonvulsant tolerance, and dependence liability. In a search for safer and more effective anticonvulsant BZs against OP-induced seizure and neuronal damage, we have previously shown that imidazenil (IMD), a low-intrinsic efficacy positive allosteric modulator of gamma-aminobutyric acid (GABA) action at α1-containing GABA(A) receptors, which has high intrinsic efficacy at α2-, α3-, and α5-containing GABA(A) receptors, is more potent and longer lasting than DZ pretreatment at protecting rats from diisopropyl fluorophosphate (DFP)-induced electrocorticographic (ECoG) seizures and neuronal damage. The effects of IMD were observed at doses that are devoid of sedative, amnestic, and anticonvulsant tolerance actions. Read More

View Article and Full-Text PDF
March 2011
Similar Publications

L-methionine decreases dendritic spine density in mouse frontal cortex.

Authors:
Patricia Tueting John M Davis Marin Veldic Fabio Pibiri Bashkim Kadriu Alessandro Guidotti Erminio Costa

Neuroreport 2010 Jun;21(8):543-8

Department of Psychiatry, Psychiatric Institute, College of Medicine, University of Illinois at Chicago, USA.

Schizophrenia postmortem brain is characterized by gamma aminobutyric acid downregulation and by decreased dendritic spine density in frontal cortex. Protracted L-methionine treatment exacerbates schizophrenia symptoms, and our earlier work (Tremolizzo et al. and Dong et al. Read More

View Article and Full-Text PDF
June 2010
Similar Publications

Varenicline treatment decreases DNMT1 mRNA expression in lymphocytes of schizophrenic patients who are cigarette smokers.

Authors:
Robert C Smith Adrian Zhubi Ekrem Maloku Henry Sershen Abel Lajtha John M Davis Erminio Costa Alessandro Guidotti

Schizophr Res 2010 Jun 23;119(1-3):269-70. Epub 2010 Mar 23.

View Article and Full-Text PDF
June 2010
Similar Publications

Anticonvulsant, anxiolytic, and non-sedating actions of imidazenil and other imidazo-benzodiazepine carboxamide derivatives.

Authors:
James Auta Bashkim Kadriu Pietro Giusti Erminio Costa Alessandro Guidotti

Pharmacol Biochem Behav 2010 Jun 19;95(4):383-9. Epub 2010 Mar 19.

Psychiatric Institute, Department of Psychiatry, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA.

Recent evidence suggests that alpha1-containing GABA(A) receptors mediate the sedative, amnestic, and to some extent the anticonvulsant actions of non-selective benzodiazepine (BZ) receptor ligands, such as diazepam (DZ). Anxiolytic and in part, anticonvulsant actions of BZ ligands are mediated by alpha2-, alpha3-, and alpha5-containing GABA(A) receptors. This has resulted in increasing interest in developing BZ ligands with selective actions at GABA(A) receptors, including alpha2-, alpha3-, and alpha5-subunits, but devoid of efficacy at alpha1-containing receptors. Read More

View Article and Full-Text PDF
June 2010
Similar Publications

Lower number of cerebellar Purkinje neurons in psychosis is associated with reduced reelin expression.

Authors:
Ekrem Maloku Ignacio R Covelo Ingeborg Hanbauer Alessandro Guidotti Bashkim Kadriu Qiaoyan Hu John M Davis Erminio Costa

Proc Natl Acad Sci U S A 2010 Mar 11;107(9):4407-11. Epub 2010 Feb 11.

Department of Psychiatry, Psychiatric Institute, University of Illinois, Chicago, IL 60612, USA.

Reelin is an extracellular matrix protein synthesized in cerebellar granule cells that plays an important role in Purkinje cell positioning during cerebellar development and in modulating adult synaptic function. In the cerebellum of schizophrenia (SZ) and bipolar (BP) disorder patients, there is a marked decrease ( approximately 50%) of reelin expression. In this study we measured Purkinje neuron density in the Purkinje cell layer of cerebella of 13 SZ and 17 BP disorder patients from the McLean 66 Cohort Collection, Harvard Brain Tissue Resource Center. Read More

View Article and Full-Text PDF
March 2010
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap